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Low-Intensity Electromagnetic Millimeter Waves for Pain Therapy
Taras I. Usichenko, Hardy Edinger, Vasyl V. Gizhko, Christian Lehmann,
Michael Wendt and Frank Feyerherd
Department of Anesthesiology and Intensive Care Medicine, Ernst Moritz Arndt University, Greifswald, Germany
Millimeter wave therapy (MWT), a non-invasive complementary therapeutic technique is claimed to
possess analgesic properties. We reviewed the clinical studies describing the pain-relief effect of
MWT. Medline-based search according to review criteria and evaluation of methodological quality of
the retrieved studies was performed. Of 13 studies, 9 of them were randomized controlled trials
(RCTs), only three studies yielded more than 3 points on the Oxford scale of methodological quality
of RCTs. MWT was reported to be effective in the treatment of headache, arthritic, neuropathic and
acute postoperative pain. The rapid onset of pain relief during MWT lasting hours to days after, remote
to the site of exposure (acupuncture points), was the most characteristic feature in MWT application for
pain relief. The most commonly used parameters of MWT were the MW frequencies between 30 and 70
GHz and power density up to 10 mW cm
 2. The promising results from pilot case series studies and
small-size RCTs for analgesic/hypoalgesic effects of MWT should be verified in large-scale RCTs on
the effectiveness of this treatment method.
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Introduction
Inadequate pain therapy increases both morbidity and health
care costs (1,2). The dominant method of pain control in
modern medicine, pharmacotherapy, can cause numerous
side effects (3–5). In order to increase the quality of pain man-
agement, various complementary non-pharmacological anal-
gesic techniques, including millimeter wave therapy (MWT),
have been tested (6). MWT is a non-invasive technique, con-
sisting of the exposure of parts of the human body to electro-
magnetic radiation with frequencies 30–300 GHz (extremely
high frequency electromagnetic field) and corresponding
wavelengths from 10 to 1 mm (7). The discovery of resonance-
like frequency dependence of biological effects of millimeter
waves (MW) provided the theoretical background for their
clinical application (8,9). Industrial continuous-wave genera-
tors (e.g. G4-142) using the backward-wave oscillator or
Gunn diode-based generators are used for MWT (Fig. 1). Low
intensity (<10 mW cm
 2) electromagnetic radiation produced
by MW generators causes no direct physical damage, ioniza-
tion nor heating (<0.5 C) of exposed surface (10). More than
50 diseases and conditions have been claimed to be treated
successfully with MW alone, or in combination with other
treatment modalities, in over 3 million patients of the former
USSR (11,12). One of the most common therapeutic effects
of MW reported during the treatment of different diseases
was the relief of concomitant pain (6,10,11). On the other
hand, there are numerous experimental studies demonstrating
the potential analgesic effects of MW in different parts of the
nociceptive system (13–18). Distinguishing analgesia among
the other therapeutic effects of MWT, the National Center
for Complementary and Alternative Medicine (NCCAM)
classified this form of treatment as one of the major areas of
complementary and alternative medicine (19).
The aim of this literature review was to retrieve all clinical
studies where the pain relief effect of MWT was described,
to evaluate their methodology and to compare the essentials
of research procedure and results of these studies in order to
recommend the directions for future clinical research on
MWT in pain therapy.
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We performed a Medline-based search and analysis of clinical
studies describing the analgesic effects of MWT. This proce-
dure was completed by a search of the catalog in the Ukranian
Scientific Medical Library according to the following criteria:
MW with frequency range 30–300 GHz, applied closely to
the surface of the body; key words: ‘millimeter waves’,
‘microwave resonance therapy’, ‘clinical study’, ‘pain relief’,
‘analgesic effects’ were used in our Medline search; only the
original full articles were included; all papers were studied in
full format. The methodological quality of the studies was
evaluated using the 5-point Oxford scale (20).
Results
According to the search criteria 13 studies were identified and
grouped according to the clinical indications (Table 1). Nine
of them fulfilled the criteria of randomized controlled trials
(RCTs). Only three RCTs yielded more than 3 points on the
Oxford scale used to evaluate the methodological quality of
the RCTs.
Volunteer Study
Radzievsky et al. performed the first classical physiological
evaluation of hypoalgesic MW effect in a subject-evaluator
blinded experimental study. The cold pressor test was used as
a model of tonic aching pain, induced by immersing the hand
of the volunteer in a cold water bath. Twelve healthy males
were randomly exposed to an active medical MW generator
for 30 min and the other time to a disabled sham generator
with at least 24 h between exposures. Skin of the lower part
of sternum of each volunteer was exposed to both true and
sham generators in a random blinded manner. The character-
istics of the active generator were frequency 42.25 GHz
(corresponding wavelength 7.1 mm) and power density
30 mW cm
 2. MW produced a suppression of pain sensation.
Pain tolerance (measured as the time between the immersion
of the hand in cold water and the onset of pain) increased by
38%. Pain sensitivity range (difference between pain tolerance
and pain threshold values) increased by almost 50% (Fig. 2).
Out of 12 volunteers, 7 reacted to the active MW generator
with an increased pain tolerance. Heart rate, arterial blood




In a retrospective analysis of 204 patients with atherosclerosis
of extracranial arteries, treated only with MW, Kuz’menko
described the complete relief of headache in 122 out of 177
patients with pre-stroke forms of cerebrovascular pathology
(22). Depending on the localization of clinical symptoms,
areas of carotid sinus or vertebral arteries were exposed to
broadband frequency MW of 54–78 GHz and power density
of 1–3 mWc m
 2. The duration of exposure was 10–20 min,
the total number of treatment sessions ranged from 4 to 6.
Along with the improvement of incomplete cognitive, motor
and sensory deficits after MWT the author reported increased
concentration of high-density lipoproteins, decrease of triglyc-
erides and increased number of T-lymphocytes in comparison
with baseline. A prospective controlled follow-up study
revealed that 65% of patients treated with MWT remained in
remission for  1year versus 20% of patients from the matched
control group, who received standard medication.
In another RCT on treatment of 56 patients with essential
hypertension with MW versus intravascular laser application,
A
B
Figure 1. Generators of electromagnetic millimeter waves. (A) Industrial
continuous-wave generator G4-142 (Russia) using the backward-wave oscilla-
tor. 1-frequency out selector; 2-output power regulator; 3-output power indica-
tor; 4-waveguide, applied to acupuncture point LI4. (B) Gunn diode-based
generator DD 21-10 (Ukraine), over the LI4 point. 1-generator; 2-waveguide;
3-cable for DC supply; 4-extension arm (reproduced with permission,
references 27,28).
202 Millimeter waves for pain therapyNikula et al. noticed that 18 out of 20 patients of MWT group
reported the complete relief of their headache already during
the first MWT session, whereas the patients of the laser group
reported pain relief after the second session (23). MW noise of
60–63 GHz was applied bilaterally to acupuncture points ST
32 (20 min of exposure), PC 7 and PC 8 (10 min of exposure
for each point). The total number of MWT sessions was 7.
The nomenclature of acupuncture points is given according
to the international classification approved by the experts of
World Health Organization (24).
Joint Pain
Bakaliuk et al. studied the effects of MWT in patients
with primary osteoarthritis (OA), applied additionally to
conventional medication. One hundred and fourteen patients
were randomized either to treatment with conventional
medication (NSAIDs and chondroprotective agents, N ¼ 20,
group I) or to conventional medication þ MWT (N ¼ 94,
group II). MW with frequency 55–62 GHz and power density
10 mWc m
 2 were applied to 4–5 acupuncture points
according to the OA localization, widely using the painful
points around the affected joints (25). The time of exposure
was 20 min and the total number of sessions was 10. The
authors reported reduced pain intensity, expressed as a joint
pain index, diminished joint stiffness and lower level of
C-reactive protein (CRP) in group II in comparison with
group I after treatment. Also they found an increased number
of T- and decreased number of B-lymphocytes and
immunoglobulins (Ig) A and M in patients treated addition-
ally with MW. They noticed that the pain-relief and anti-
inflammatory effect of MWT had already taken place after
the second or at least third treatment session, whereas the
effect of other forms of treatment wasn’t seen until after
several days. It remains unclear whether the patients and
investigators were blinded to MWT.
Shliapak et al. reported the beneficial effects of MW in the
treatment of children with juvenile rheumatoid arthritis (26).
One hundred thirty-eight children were randomly assigned to
three intervention groups. In group I the MW with fixed fre-
quency 53.5 GHz were applied directly to the affected joints
30 min every day for 10 days. In group II the MW with the
same parameters were applied bilaterally to the same acupunc-
ture points (GV 20, GB 20, ST 36, LI 4 and BL 40) in all
patients, independent of the localization of the affected joints.
The number of the treatments was 6, the duration of exposure
to MW was 30 min for every acupuncture point. In patients
from group III MWT was applied to 2 acupuncture points.
One of them (CV 22) was situated in the jugular notch and
was exposed to MW during each treatment. The second point
was chosen near the most effected (painful and swollen) joint








Site of MW application Design Oxford
scale
Source/year
Experimental pain Immersion in cold water 12 42.25 30 Lower third of sternum RCT crossover 5 (21)/1999
Headache Cerebral atherosclerosis 204 54–78 0.003 Carotid sinus, vertebral arteries nRCT 0 (22)/1998
Essential hypertension 56 60–63 Missed AP RCT 1 (23)/1992
Joint pain Primary OA 114 55–62 0.01 AP RCT 1 (25)/1998
JRA 138 53.5 AP RCT 1 (26)/1996
DCTD 12 54–78 2.5 Periarticular tender points Case series 0 (27)/2003
RA 12 54–64 2.5 AP RCT 5 (28)/2003
Postoperative pain Brain lesions 42 42.25 & 53.5 10 Hands and feet Case series 0 (29)/1998
Abdominal surgery 141 37 1 Wound area RCT 4 (31)/1995
Oral mucous pain Lichen planus 30 42.25 10 Perioral area RCT 3 (32)/2001
‘Burning mouth’ 80 42.25 10 Perioral area RCT 3 (33)/2003
Neuropathic pain Trigeminal neuralgia 52 42.25 10 Branches of trigeminal nerve RCT 2 (34)/1995
N, number of subjects in the study; MW, millimeter waves; nRCT, non-randomized controlled trial; AP, acupuncture points; JRA, juvenile rheumatoid arthritis;
OA, osteoarthritis; DCTD, diffuse connective tissue disease; RA, rheumatoid arthritis.
Figure 2. Both the threshold and tolerance of experimentally induced pain
in 12 healthy volunteers increased after exposure to electromagnetic
millimeter waves in comparison to sham procedure (details see in the text).
Pain characteristics, measured in seconds, expressed here as means ± SEM,
*difference is statistically significant (P < 0.05) (reproduced with permission
from reference 21).
eCAM 2006;3(2) 203(e.g. GB 34, near the knee joint; BL 60, ankle; LI 5, wrist;
GB 30, hip joint).
The intensity of joint pain decreased by 50% in all three
groups after MWT. The duration of morning stiffness and the
circumference of the affected joints also decreased, and
the functional joint status improved in 80–90% of children.
The relief of joint symptoms was more pronounced in patients
of group III, where the MW were applied to the acupuncture
points situated near the thymic zone and the most affected
joints (27). Moreover, the authors reported that the con-
centration of circulating immune complexes, B-lymphocytes
and immunoglobulin G decreased and the number of
T-lymphocytes and IgA increased during the course of MWT
in patients from group III in comparison with the patients
from other 2 study groups.
Encouraged by these findings, we applied MW for treat-
ment of chronic joint pain in patients with diffuse connective
tissue diseases (DCTD) (27). Twelve patients with joint pain
syndromes of DCTD origin received MWT in addition to their
analgesic medication with non-steroidal anti-inflammatory
drugs. MWT procedure included the exposure of tender sites
around the painful joints to electromagnetic MW with band
frequency 54–78 GHz and power density 2.5 mW cm
 2. The
time of exposure was 35 ± 5 min and the total number of ses-
sions ranged from 5 to 10 depending on the course of under-
lying DCTD. Intensity of joint pain, medication requirement
and joint stiffness were taken before, during and immediately
after the treatment, and after a 6-month follow-up. Pain inten-
sity, joint stiffness and required medication decreased after
the treatment and remained at the same level throughout the
follow-up period. MWT applied to tender points around the
affected joints was safe under the conditions of this case series
study.
Thus as a next step in order to verify the effects of MW in the
treatment of joint pain we started a randomized patient-
evaluator blinded study in patients with rheumatoid arthritis
(RA) (28). Twelve patients with RA were exposed to MW
with band frequency 54–64 GHz and power density 2.5 mW
cm
 2. MW were applied to the acupuncture points painful on
palpation situated near the affected joints. Four acupuncture
points (two symmetric pairs) were consecutively exposed
to MW during one session. Total duration of exposure was
40 min. The total number of sessions ranged from 5 to 9
(median 7) over 2 weeks. Double blinding of the treatment
was provided by a computer, which was programmed to ran-
domize patients into three groups and drive MW generators.
According to the study design, group I received only real
MWT sessions, group II only sham MWT procedure.
Group III was exposed to MW in a random crossover manner.
Pain intensity, joint stiffness and laboratory parameters were
recorded before, during and immediately after the treatment.
The study was discontinued because of beneficial therapeutic
effects of MWT. Patients from group I (n ¼ 4) reported sig-
nificant pain relief and reduced joint stiffness during and after
the course of therapy. Patients from group II (n ¼ 4) revealed
no improvement during the study. Patients from group III
reported changes regarding pain and joint stiffness only after
real MW sessions (Fig. 3). Monitored laboratory parameters:
blood cell count, ESR and CRP did not change significantly
after the treatment course in comparison to the baseline.
Postoperative Pain
Tyshkevich et al. reported the relief of postoperative pain after
craniotomy in 42 patients aged 3–54 years when treated with
MW in a case series study (29). MW with fixed frequencies
42.25 and 53.53 GHz (corresponding wavelengths 7.1 and
5.6 mm) and power density 10 mW cm
 2 were applied to the
palms of the hands and the soles of the feet for 2–7 min per
field of exposure daily or every other day for 3 weeks after sur-
gery. The total number of MWT sessions ranged from 5 to 10.
An additional course of MWT, if indicated, was performed
2 months after the first treatment. The authors observed
complete relief of postoperative cranial pain after 3–5 MWT
sessions followed by improvement of cognitive brain function,
although these parameters were described only qualitatively.
Out of 42 patients studied, 30 suffered postoperative epilepsy
(focal and generalized seizures). During the MWT the inci-
dence of seizure episodes was reduced without additional
pharmacological treatment. The clinical improvement was
accompanied by a normalization of the bioelectric brain
activity (stabilization of a-rhythm) and disappearance of the
pathologically slow d-waves monitored by means of electro-
encephalography(25).Becausethestudydidnothave acontrol
group, it is impossible to distinguish the described improve-
ment from the natural course of postoperative recovery.
Based on their previous experimental success in treat-
ment with electromagnetic MW of wounds infected with
Staphylococcis aureus in rabbits (30), Korpan and Saradeth
performed a randomized patient-evaluator blinded clinical
trial on the effects of MWT for wound treatment in patients
after abdominal surgery (31). One hundred forty-one patients
were randomly divided into two groups: group I (N ¼ 71)
Figure 3. Pain intensity according to a numerical rating scale from 0 to 10
(NRS-11, ranged from 0 ¼ no pain to 10 ¼ worst imaginable pain) in two
patients with rheumatoid arthritis, who were exposed to MWT in crossover
manner. Filled arrows, real; hollow arrows, sham MWT sessions (reproduced
with permission from reference 28).
204 Millimeter waves for pain therapyreceived MWT with frequency 37 GHz and power density
1m Wc m
 2, group II (control group) was treated with an inac-
tive MWT generator (sham procedure). MW were applied
directly to the wound areas for 30 min on 7 consecutive
days. The accelerated wound healing was accompanied by
clinically remarkable reduction of postoperative pain in
group I, treated with the active device in comparison with the
control group. The intensity of postoperative pain, measured
on the numerical rating scale NRS-4 decreased already on
the third postoperative day in >90% of patients in group I,
whereas in group II satisfying wound healing took place in
only 25% within the same period (Fig. 4).
Other Reported Applications with Pain Relief
The research group from the Oral Medicine Department of
Sichuan University, China, studied clinical and immunological
effects of millimeter waves in patients with oral lichen planus
(OLP). Thirty patients with OLP were randomly assigned to
receive either MWT or conventional medication (N ¼ 15 per
group). After the MWT with frequency 43 GHz (correspond-
ing wavelength 7.1 mm) and power density 10 mW cm
 2,
along with the decrease of CD8þ positive T-lymphocytes in
patients from MWT group, the authors found decreased pain
intensity in comparison with the control group (32).
The same research group studied the effects of MWT in
patients with ‘burning mouth’ syndrome (BMS). Eighty
patients were randomized into four groups: group I, MWT
and conventional medication; group II, MWT alone; group III,
sham MWT and conventional medication; group IV,
medication alone. After MWT was applied to the perioral
zone with the same output parameters as in their previous
study the authors registered decreased pain intensity in the
groups I and II treated with MW in comparison with group IV
(conventional medication) but not with sham MWT þ
medication, suggesting the placebo effect of MWT (33).
Megdiatov et al. reported effective application of MWT in
patients with trigeminal neuralgia. Fifty-two patients were
randomly allocated to receive either MW (group I) or sham
procedure—inactive MW generator (group II) additionally to
conventional medication. The MW radiation with 42.25 GHz
and power density 10 mW cm
 2 was applied to areas where
branches of the trigeminal nerve approach the skin. The num-
ber of MWT sessions was 10, duration of each session was
15 min. Out of 27 patients from group I (real MWT), 19
reported reduced pain intensity and decreased incidence of
neuralgia attacks in comparison to 4 out of 25 patients from
the control group, who received sham MWT procedure (34).
In a case series study of the MWT effects in 39 patients with
chronic neuropathic pain from cancer of abdominal origin
Grubnik et al. described pain relief effect already during the
first treatment session (35). During the course of MWT all
patients gradually reduced and completely stopped their
analgesic medication with opioid drugs. An improvement of
night sleep, appetite and intestinal function was registered
after MWT in 36 patients. Thirty-two patients reported an
improvement in life quality.
Immediate pain relief from MWT (during the first treatment
session) was reported in a number of retrospective studies
without control group, where MW was used to treat vertebral
osteochondrosis. An analysis of these studies is precluded by
insufficient description of the study methods as well as the
absence of clear outcome measures (36,37).
Side Effects
In the studies reviewed the authors did not report any
health-related side effects of MWT. Slight paresthesias, previ-
ously mentioned in several case reports and non-controlled
case series (10,11), appeared in almost 50% of patients in
studies where the effects of MWT were carefully described
(21,27,28,31). The paresthesias were of short duration and
reported as pleasant (‘warmth’) or neutral. General fatigue
and sleepiness during the treatment sessions in almost 80%
of the patients was a rather desirable side effect of MWT, as
also described in previous reviews on biomedical effects of
MWT (10,11,21,27,28).
Methodological Quality of Reviewed Studies
Only three (21,28,31) out of the nine randomized controlled
studies described a randomization method, which was appro-
priate for this purpose. Also only two out of three these studies
mentioned the withdrawal criteria and defined the analgesic
effect as the primary endpoint of investigation, expressed
either as pain intensity/tolerance or analgesic requirement
(21,28). The majority of other studies reported the analgesic
effect of MW as an additional finding. For future studies on
the effectiveness of MWT for pain relief such primary
endpoints as pain intensity and analgesics requirement are
probably the most suitable outcome measures. Owing to the
individual variability of patients’ responses to both placebo
and active treatment, more than 40 per group are recom-
mended by the experts (38).
Figure 4. The accelerated wound healing in patients treated with millimeter
waves (MW) after abdominal surgery (A) was accompanied by pronounced
reduction of postoperative pain (B) in comparison with the control group
(‘d’ means days on the x-axis). The significant reduction of postoperative
pain intensity, measured on numerical rating scale NRS-4, was registered on
the third day after the surgery in more than 90% of patients treated with MW
(modified according to reference 31).
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The most characteristic feature of the pain-relief effect of MW
described was the immediate onset of analgesia/hypoalgesia
during the application of MWT. Pain relief from MW was
already detectable after several minutes of exposure and
lasted from several hours to several days. A typical example
is presented on the graph of individual pain intensity measure-
ment during the course of MWT, where the real and sham
MWT sessions were applied intermittently [Figure 3 from
(29)]. The improvement of other clinical (wound clearance,
joint stiffness) and laboratory parameters (inflammation and
immunological values) was delayed several days (Fig. 4).
MW probably influences the immune system: at least it was
shown in patients with disorders where the immune system
was affected (25,26,32). Radzievsky et al. recently showed
an intriguing aspect of the involvement of the endogenous
opioid system in the anticancer effect of MW. They exposed
the murine experimental model of subcutaneous melanoma to
MW with frequency 61.22 GHz and power density 13.3 mW
cm
 2 during 15 min for 5 days. MW exposures started at the
fifth day following melanoma cell injection suppressed sub-
cutaneous tumor growth. Pretreatment with naloxone (a non-
specific antagonist of opioid receptors) completely abolished
the MWT-induced suppression of melanoma growth (39).
The other common finding was the effect of MW remote to
the site of exposure. Almost all the authors applied MW to
acupuncture points or equivalent sites (Table 1). The other
application sites of MW were the lower part of the sternum,
tender points, painful joints, wounds, etc. All these are con-
sidered acupuncture points (or the parts of impaired energy
flow along the meridians) from the point of view of Traditional
Chinese Medicine (40). According to the existing data it is
not possible yet to evaluate the role of the site of exposure.
It should be verified in rigorously controlled trials.
The time of exposure ranged from 10 to 60 min in the studies
reviewed. However, there is still no data on the influence of
shorter or longer exposure on the outcome of MWT.
So far there are no clinical studies comparing the effective-
ness of the noise electromagnetic MW radiation versus fixed
frequencies. The claim of several authors that the frequencies
45.25, 53.57 and 61.22 GHz possess therapeutic properties
and are free from side effects was not verified by sufficient
data (10,41,42). Sharp resonance-like frequency dependence
was described for effects of low-intensity MW only in vitro
(8,9,43–45). Samosiuk et al. provided the evidence for an
optimal frequency of MW in pain treatment in an animal
experiment. The authors compared the fixed frequencies 60
and 118 GHz with noise MW radiation of frequency range
42–95 and 90–140 GHz in the model of formalin-induced
nociceptive behavior reaction (licking of wounded hind paw)
in experimental mice. They found out that the strongest
analgesia was achieved under the exposure to the noise MW
radiation of 42–95 GHz (46).
Almost all findings were described using MW with power
density ranged 1–10 mW cm
 2. This power of MWT has
been reported to be safe and free of health hazards (13). The
data from experimental research have clearly shown that the
increase of the radiation power of MW does not increase
the biological effect, i.e. there was a sealing effect in the range
of maximally 10 mW cm
 2 (43). This power might be suffi-
cient to achieve optimal clinical effects of MWT, although
the appropriate studies have not been yet reported.
Conclusion and Directions for
Future Research
We conclude that there is promising data from pilot case series
and small-scale randomized controlled trials for analgesic/
hypoalgesic effects of electromagnetic millimeter waves in
frequency range 30–70 GHz. Large-scale randomized con-
trolled trials on the effectiveness of this non-invasive therapeu-
tic technique are necessary. The effects of MW applied with
selected frequencies should be compared with those of broad-
band MW. The most intriguing question for future research
might be the evaluation of the role of the exposure site,
especially in relation to the topography of the acupuncture
meridian system.
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